InvestorsHub Logo
Followers 130
Posts 14996
Boards Moderated 1
Alias Born 06/04/2018

Re: None

Monday, 06/24/2019 4:30:46 PM

Monday, June 24, 2019 4:30:46 PM

Post# of 9287
News: $NAVB Navidea Biopharmaceuticals Announces SNMMI Press Release and Recognition of Phase 1/2 Study Results

Navidea Biopharmaceuticals, Inc. (NYSE American:NAVB) (“Navidea” or the “Company”), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, is pleased to announce that the results of the Company’s NAV3-21 clinical st...

Read the whole news https://marketwirenews.com/news-releases/navidea-biopharmaceuticals-announces-snmmi-press-release-and-recognition-of-phase-1-2-study-results-8403980.html
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NAVB News